Chromatographic analysis of triple cough therapy; bromhexine, guaiafenesin and salbutamol and pharmaceutical impurity: in-silico toxicity profile of drug impurity
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Chromatographic analysis of triple cough therapy; bromhexine, guaiafenesin and salbutamol and pharmaceutical impurity: in-silico toxicity profile of drug impurity ; volume:18 ; number:1 ; day:27 ; month:1 ; year:2024 ; pages:1-15 ; date:12.2024
BMC chemistry ; 18, Heft 1 (27.1.2024), 1-15, 12.2024
- Urheber
-
Sharkawi, Marco M. Z.
Safwat, Mark T.
Abdelaleem, Eglal A.
Abdelwahab, Nada S.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13065-024-01122-5
- URN
-
urn:nbn:de:101:1-2024040812552795855623
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:56 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Sharkawi, Marco M. Z.
- Safwat, Mark T.
- Abdelaleem, Eglal A.
- Abdelwahab, Nada S.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Impurity profiling of challenging active pharmaceutical ingredients without chromophore
Impurity Profiling of Challenging Active Pharmaceutical Ingredients without Chromophore
XIX. Funeral ceremonies … XXIII. Impurity
Solvable self-dual impurity models
Impurity-assisted tunneling in graphene
6. The Gentile's grave levitical impurity.
BPS soliton-impurity models and supersymmetry
Dynamic Impurity Redistributions in Kesterite Absorbers
Impurity lattice Monte Carlo for hypernuclei
Improved modelling of impurity transport in tokamaks
Renormalization group methods for quantum impurity systems
3. The levitical impurity of the Gentile.
Impurity profiling of challenging active pharmaceutical ingredients without chromophore
Impurity Profiling of Challenging Active Pharmaceutical Ingredients without Chromophore
XIX. Funeral ceremonies … XXIII. Impurity
Solvable self-dual impurity models
Impurity-assisted tunneling in graphene
6. The Gentile's grave levitical impurity.
BPS soliton-impurity models and supersymmetry
Dynamic Impurity Redistributions in Kesterite Absorbers
Impurity lattice Monte Carlo for hypernuclei
Improved modelling of impurity transport in tokamaks
Renormalization group methods for quantum impurity systems
3. The levitical impurity of the Gentile.
Impurity profiling of challenging active pharmaceutical ingredients without chromophore
Impurity Profiling of Challenging Active Pharmaceutical Ingredients without Chromophore
XIX. Funeral ceremonies … XXIII. Impurity
Solvable self-dual impurity models
Impurity-assisted tunneling in graphene
6. The Gentile's grave levitical impurity.
BPS soliton-impurity models and supersymmetry
Dynamic Impurity Redistributions in Kesterite Absorbers
Impurity lattice Monte Carlo for hypernuclei
Improved modelling of impurity transport in tokamaks
Renormalization group methods for quantum impurity systems